Sparc
- All
- News
-
Education Ministry Releases Rs 80 Crore To IIT Kharagpur As SPARC Grant
This Education Ministry’s grant of Rs 80 crore to IIT Kharagpur has been released for the second phase of Scheme for Promotion of Academic and Research Collaboration (SPARC) Programme.
-
IIT Madras, German Researchers Collaborate To Develop New Green Energy Materials
IIT Madras Researchers have collaborated with German Researchers to develop new materials for Green Energy Solutions.
-
HRD Announces Exchange Programme To 14 European Countries. Apply Now
Starting from 2020, every year, DUO-India aims to fund 100 students-pairs for exchanges for one semester to improve mobility between Indian and European institutes.
-
Kashmir University Qualifies For SPARC Scheme
University of Kashmir which figures among the top 100 universities as per NIRF ranking comes under the SPARC programme.
-
Research Work Under IMPRESS, SPARC Schemes To Begin In January 2019: HRD Minister
"A country achieves prosperity on a sustainable basis only through innovation which can happen only by good research and which is currently a major focus area of the government," he said while addressing a press conference.
-
MHRD Launches SPARC, IMPRESS Portals To Promote Research And Innovation
MHRD, today, launched two web portals which will serve to promote research and innovation in the country.
-
US Drug Regulator Subjects SPARC Xelpros Nod To 'Satisfactory Resolution'
Sun Pharma Advanced Research Company today said the US health regulator has not approved its new drug application for Xelpros, a preservative-free eye drop.
-
SPARC Reports Q2 Net Profit At Rs 15 Crore
Its standalone total income from operations also rose to Rs 94.89 crore during the quarter under consideration.
-
Sun Pharma Advanced Research Q1 Loss Widens To Rs 36 Crore
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported widening of standalone net loss to Rs 36.41 crore for the first quarter that ended on June 30.
-
SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma
Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
SPARC Q4 Net Loss Widens To Rs 9.6 Crore
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.
-
SPARC Gets Sebi Nod to Mop up Rs 250 Crore Via Rights Issue
Drug discovery firm Sun Pharma Advanced Research Company (SPARC) has received markets regulator Sebi's approval to raise up to Rs 250 crore through a rights issue.
-
Oracle Unveils Sparc M7 Processor for Better Security, Efficiency
The Sparc M7 processor incorporates unique hard-wired security and performance functions using a technique known as "software in silicon".
-
Sun Pharma, SPARC Fall As US Revokes Nod for Epilepsy Drug
The US regulator cited pending compliance issue at Sun Pharma's Halol facility for revoking its approval for Elepsia XR (Levetiracetam ER). SPARC was to manufacture a compound of the epilepsy drug at the Halol unit.
-
Education Ministry Releases Rs 80 Crore To IIT Kharagpur As SPARC Grant
This Education Ministry’s grant of Rs 80 crore to IIT Kharagpur has been released for the second phase of Scheme for Promotion of Academic and Research Collaboration (SPARC) Programme.
-
IIT Madras, German Researchers Collaborate To Develop New Green Energy Materials
IIT Madras Researchers have collaborated with German Researchers to develop new materials for Green Energy Solutions.
-
HRD Announces Exchange Programme To 14 European Countries. Apply Now
Starting from 2020, every year, DUO-India aims to fund 100 students-pairs for exchanges for one semester to improve mobility between Indian and European institutes.
-
Kashmir University Qualifies For SPARC Scheme
University of Kashmir which figures among the top 100 universities as per NIRF ranking comes under the SPARC programme.
-
Research Work Under IMPRESS, SPARC Schemes To Begin In January 2019: HRD Minister
"A country achieves prosperity on a sustainable basis only through innovation which can happen only by good research and which is currently a major focus area of the government," he said while addressing a press conference.
-
MHRD Launches SPARC, IMPRESS Portals To Promote Research And Innovation
MHRD, today, launched two web portals which will serve to promote research and innovation in the country.
-
US Drug Regulator Subjects SPARC Xelpros Nod To 'Satisfactory Resolution'
Sun Pharma Advanced Research Company today said the US health regulator has not approved its new drug application for Xelpros, a preservative-free eye drop.
-
SPARC Reports Q2 Net Profit At Rs 15 Crore
Its standalone total income from operations also rose to Rs 94.89 crore during the quarter under consideration.
-
Sun Pharma Advanced Research Q1 Loss Widens To Rs 36 Crore
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported widening of standalone net loss to Rs 36.41 crore for the first quarter that ended on June 30.
-
SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma
Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
SPARC Q4 Net Loss Widens To Rs 9.6 Crore
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.
-
SPARC Gets Sebi Nod to Mop up Rs 250 Crore Via Rights Issue
Drug discovery firm Sun Pharma Advanced Research Company (SPARC) has received markets regulator Sebi's approval to raise up to Rs 250 crore through a rights issue.
-
Oracle Unveils Sparc M7 Processor for Better Security, Efficiency
The Sparc M7 processor incorporates unique hard-wired security and performance functions using a technique known as "software in silicon".
-
Sun Pharma, SPARC Fall As US Revokes Nod for Epilepsy Drug
The US regulator cited pending compliance issue at Sun Pharma's Halol facility for revoking its approval for Elepsia XR (Levetiracetam ER). SPARC was to manufacture a compound of the epilepsy drug at the Halol unit.
